Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07245914 · ClinicalTrials.gov registry record
A Consumer Health Study Evaluating the Impact of Pivit on Weight Loss and Appetite in Overweight Individuals
A clinical trial of Obesity & Overweight and Obesity (Body Mass Index >30 kg/m2), sponsored by Olfactive Biosolutions.
- Active
- Registry status
- 125
- Enrollment target
- 1
- Study location
NCT07245914: Active study of Obesity & Overweight and Obesity (Body Mass Index >30 kg/m2), sponsored by Olfactive Biosolutions.
NCT07245914 is a study of Obesity & Overweight and Obesity (Body Mass Index >30 kg/m2) that is active but no longer recruiting, run by Olfactive Biosolutions. The registered enrollment target is 125 participants, above the 111-participant average among 28 other Obesity & Overweight trials with a reported enrollment target (13% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07245914, a study of Obesity & Overweight and Obesity (Body Mass Index >30 kg/m2), is active but no longer recruiting, sponsored by Olfactive Biosolutions.
- ACTIVE NOT RECRUITING
- Registry status
- 125 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to observe the impact of Pivit on body weight in overweight individuals. Additionally, the study aims to observe the impact of the product on appetite, hunger, cravings, and general well-being via activities and technologies that can successfully and effectively be completed in a home setting. A consumer-driven, decentralized observational clinical research study is therefore well-suited for examining the impact of this product in this population. The study team will examine the outcomes in a broad age-range of adults who have chosen to try this product. The study will incorporate participant reported outcome questionnaires and surveys and at-home body weight measurement using a personal scale. There is no "doctor-patient" relationship as part of this research since the participant as a consumer is making the informed choice to take the product and take part in the observational process with self-reported measures and at-home body weight measurement. Findings from this study will contribute knowledge toward the tolerability and formulation of the plant-derived consumer product and the design of future studies.
Primary Outcome
The primary outcome measure for this study will be to observe the impact of the study product, Pivit, on individual weight. This will be measured by assessing the change from baseline in body weight after three months of study product use.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT The Study Product (Pivit)
Study Locations (1)
California
- People Science - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2025-07-30 |
| Est. Completion | 2026-02-26 |
What the registry record for NCT07245914 still lists
NCT07245914 is an observational study that tracks outcomes without assigning an intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, above the 111-participant average among 28 other Obesity & Overweight trials with a reported enrollment target (13% higher).
The record links to 2 conditions, with Obesity & Overweight appearing as the primary indexed condition, and to 1 intervention - of which The Study Product (Pivit) is the first listed.
NCT07245914 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07245914 about?
NCT07245914 is a clinical study titled "A Consumer Health Study Evaluating the Impact of Pivit on Weight Loss and Appetite in Overweight Individuals". The purpose of this study is to observe the impact of Pivit on body weight in overweight individuals. Additionally, the study aims to observe the impact of the product on appetite, hunger, cravings, and general well-being via activities and technologies that can successfully and effectively be compl...
What is the current status of trial NCT07245914?
This trial is currently active not recruiting. The enrollment target is 125 participants. The study started on 2025-07-30. Estimated completion is 2026-02-26.
What conditions does trial NCT07245914 study?
This clinical trial studies the following conditions: Obesity & Overweight, Obesity (Body Mass Index >30 kg/m2).
What interventions are being tested in trial NCT07245914?
The interventions under investigation include: The Study Product (Pivit) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07245914?
This trial is sponsored by Olfactive Biosolutions, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07245914 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity & Overweight
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07245914's enrollment target sits among peer trials
125 7th of 28 higher than 22 of 28 other Obesity & Overweight trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity & Overweight trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Optimizing Self-Monitoring Feedback Delivery for the Treatment of Overweight and Obesity
RECRUITING · NA
-
Microrandomized Trial to Optimize Use of Burden-reducing Self-monitoring Approaches in Behavioral Obesity Treatment
RECRUITING · NA
-
Pistachio Intake and Nutrition-Related Outcomes in Individuals on GLP-1 Therapy
RECRUITING · NA
-
Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults
RECRUITING · NA
-
Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households
RECRUITING · NA
-
Impact of Increased Body Mass Index on Adolescent Fixed Orthodontic Treatment. A Prospective Longitudinal Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI